Showing results (31-40 of 38) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
European Urology|August 23, 2022
Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled TrialWei Shen Tan, Aaron Prendergast, Charlotte Ackerman, et al.BJU International|March 4, 2020
CALIBER: a phase II randomized feasibility trial of chemoablation with mitomycin-C vs surgical management in low-risk non-muscle-invasive bladder cancerA Hugh Mostafid, Nuria Porta, Joanne Cresswell, et al.Oral Oncology|May 10, 2026
Post-treatment circulating tumor DNA clinical features, prognosis in HPV-positive oropharynx cancerScott A Roof, Ryan M Sicard, Susmita Chennareddy, et al.British Journal of Anaesthesia|April 28, 2019
The use of drug provocation testing in the investigation of suspected immediate perioperative allergic reactions: current statusLene H Garvey, Didier G Ebo, Mogens Krøigaard, et al.British Journal of Anaesthesia|May 28, 2019
Management of suspected immediate perioperative allergic reactions: an international overview and consensus recommendationsLene H Garvey, Pascale Dewachter, David L Hepner, et al.The Lancet. Oncology|October 22, 2021
A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective studyElizabeth K Bancroft, Elizabeth C Page, Mark N Brook, et al.European Urology|February 19, 2026
Targeted Prostate Cancer Screening in Carriers of BRCA1 or BRCA2 Pathogenic Germline Variants Detects Clinically Relevant Disease: 5-year Results from the IMPACT StudyElizabeth K Bancroft, Elizabeth C Page, Jana McHugh, et al.European Urology|September 21, 2019
Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation CarriersElizabeth C Page, Elizabeth K Bancroft, Mark N Brook, et al.Pageof 4